Survodutide is a new medication designed for individuals with overweight or obesity, as well as those with fatty liver disease. It is being developed as a weekly subcutaneous injection, to be used alongside a modified diet and increased physical activity. The primary aims of the studies are to achieve weight loss, improve liver function, and reduce liver inflammation. The medication works by targeting two signals in the body that regulate appetite, satiety, and energy expenditure, potentially helping to reduce food intake. Survodutide is still in the clinical research phase and has not yet been approved or made available in the European Union. We will provide updates as soon as there are any developments.
Slimming
Survodutide
Injection

In short
- For the treatment of overweight or obesity
- Not yet approved or available
- Injection with survodutide
- Potential average weight loss of up to 16.6% in clinical studies
- Side effects appear similar to those of other GLP-1 medications
What is Survodutide?
How does Survodutide work?
Side effects of Survodutide
Research on Survodutide
Status and availability
What treatments are currently available?
Scientific sources
Related products
View other options that may suit you.










